[53] demonstrated that Rev‐erbα—a nuclear receptor involved in regulating circadian rhythms, inflammation, and lipid metabolism—suppresses both glycolysis and the PPP by binding to the promoters of the PFKFB3 and G6PD genes in human gastric cancer cells, thereby limiting their proliferation. This evidence concerns the gene NR1D1 and gastric cancer.